Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Puschmann

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Human Molecular Genetics|March 2, 2013
Role of Gα(olf) in familial and sporadic adult-onset primary dystoniaSatya R Vemula, Andreas Puschmann, Jianfeng Xiao, et al.
Parkinsonism & Related Disorders|March 15, 2025
TOR1AIP2 as a candidate gene for dystonia-hemichorea/hemiballismEfthymia Kafantari, Victoria J Hernandez, Ján Necpál, et al.
Journal of Neurology|October 3, 2023
Clinical and genetic analyses of a Swedish patient series diagnosed with ataxiaSorina Gorcenco, Efthymia Kafantari, Joel Wallenius, et al.
Parkinsonism & Related Disorders|March 2, 2012
Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new casesMark S LeDoux, Jianfeng Xiao, Monika Rudzińska, et al.
Stroke|March 17, 2020
Whole-Exome Sequencing in 22 Young Ischemic Stroke Patients With Familial Clustering of StrokeAndreea Ilinca, Nicolas Martinez-Majander, Sofie Samuelsson, et al.
Alzheimer'S Research & Therapy|January 27, 2018
Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic reviewEmil Ygland, Danielle van Westen, Elisabet Englund, et al.
BMJ Quality Improvement Reports|January 7, 2016
Improving the likelihood of neurology patients being examined using patient feedbackJason Philip Appleton, Andreea Ilinca, Arne Lindgren, et al.
Parkinsonism & Related Disorders|October 23, 2018
Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?Sorina Gorcenco, Frédéric M Vaz, Anna Tracewska-Siemiatkowska, et al.
Parkinsonism & Related Disorders|May 9, 2015
Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statementAndreas Puschmann, Laura Brighina, Katerina Markopoulou, et al.
Parkinsonism & Related Disorders|April 13, 2011
Human leukocyte antigen variation and Parkinson's diseaseAndreas Puschmann, Christophe Verbeeck, Michael G Heckman, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Human Molecular Genetics|March 2, 2013
Role of Gα(olf) in familial and sporadic adult-onset primary dystoniaSatya R Vemula, Andreas Puschmann, Jianfeng Xiao, et al.
Parkinsonism & Related Disorders|March 15, 2025
TOR1AIP2 as a candidate gene for dystonia-hemichorea/hemiballismEfthymia Kafantari, Victoria J Hernandez, Ján Necpál, et al.
Journal of Neurology|October 3, 2023
Clinical and genetic analyses of a Swedish patient series diagnosed with ataxiaSorina Gorcenco, Efthymia Kafantari, Joel Wallenius, et al.
Parkinsonism & Related Disorders|March 2, 2012
Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new casesMark S LeDoux, Jianfeng Xiao, Monika Rudzińska, et al.
Stroke|March 17, 2020
Whole-Exome Sequencing in 22 Young Ischemic Stroke Patients With Familial Clustering of StrokeAndreea Ilinca, Nicolas Martinez-Majander, Sofie Samuelsson, et al.
Alzheimer'S Research & Therapy|January 27, 2018
Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic reviewEmil Ygland, Danielle van Westen, Elisabet Englund, et al.
BMJ Quality Improvement Reports|January 7, 2016
Improving the likelihood of neurology patients being examined using patient feedbackJason Philip Appleton, Andreea Ilinca, Arne Lindgren, et al.
Parkinsonism & Related Disorders|October 23, 2018
Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?Sorina Gorcenco, Frédéric M Vaz, Anna Tracewska-Siemiatkowska, et al.
Parkinsonism & Related Disorders|May 9, 2015
Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statementAndreas Puschmann, Laura Brighina, Katerina Markopoulou, et al.
Parkinsonism & Related Disorders|April 13, 2011
Human leukocyte antigen variation and Parkinson's diseaseAndreas Puschmann, Christophe Verbeeck, Michael G Heckman, et al.
Pageof 9